Consuming fructose in place of other carbohydrates lowers glycated blood proteins by a clinically significant percentage, a recent meta-analysis suggests.
Pioglitazone was associated with an increased risk of bladder cancer, but rosiglitazone was not, in a large recent meta-analysis.
Patients with type 2 diabetes who are treated with a thiazolidinedione may have an increased risk for diabetic macular edema, according to a recent study.
Using basal insulin to normalize glucose levels in patients with early diabetes and pre-diabetes doesn't affect cardiovascular event or cancer rates, a study found.
Linagliptin was non-inferior to glimepiride in lowering hemoglobin A1c in type 2 diabetes patients, according to a study designed, conducted and analyzed by linagliptin's manufacturer, Boehringer Ingelheim.
Continuous insulin provides comparable glycemic control to injections, while continuous glucose monitoring is slightly superior to self-monitoring, a meta-analysis concluded.
A meta-analysis of randomized controlled trials of patients with non–insulin-treated type 2 diabetes found that six months of self-monitoring blood glucose reduced hemoglobin A1c levels by 0.25% more than usual care.
Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.